Philips Beats Q2 Profit Estimates Due to Tariff Refunds
Comparable sales rose 4% and adjusted EBITA margin reached 16.4%, helped by a EUR 186 million US tariff refund.
- On July 28, 2026, Royal Philips reported second quarter sales of EUR 4.4 billion, reflecting 4% comparable sales growth and an Adjusted EBITA margin of 16.4%.
- A US tariff refund benefit of effectively 4.2% lifted the margin, while cost inflation and higher tariffs pressured underlying operational performance excluding this one-time gain.
- Comparable sales rose across all segments, with Personal Health increasing 8%, Connected Care growing 2%, and Diagnosis and Treatment also rising 2%.
- Philips reiterated its full-year 2026 comparable sales growth outlook of 3%-4.5% and updated its Adjusted EBITA margin guidance to 13.5%-14.0% to reflect the US tariff refund.
- Disciplined cost management and productivity initiatives delivered EUR 132 million in savings in the quarter, with the company on track to achieve EUR 1.5 billion through its 2026-2028 program.
29 Articles
29 Articles
Modern technology treats heart attacks and strokes without cutting heavily into the body. Philips sees a central growth field in the "image-leading therapy". And: The company receives tariffs from the USA.
Philips beats Q2 profit estimates due to tariff refunds
Dutch healthcare technology company Philips has reported second-quarter profit margins above market expectations, helped by US tariff refunds, and lifted its 2026 outlook to include benefits from the repaid levies.
Philips has received a financial windfall in recent months. The company received 186 million euros back from the US government due to unjustly paid import tariffs. Philips shared this upon the announcement of its latest quarterly figures. Last year, the United States imposed import tariffs on products from dozens of countries, but in February, the highest court in the US ruled that those tariffs were invalid. Companies that had paid the tariffs…
Coverage Details
Bias Distribution
- 38% of the sources lean Left, 37% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium























